An integrin inhibiting molecule decreases oxidative damage and improves neurological function after spinal cord injury.

Authors:
Feng Bao
Feng Bao
Robarts Research Institute
Canada
Yuhua Chen
Yuhua Chen
Robarts Research Institute
Canada
Lynne C Weaver
Lynne C Weaver
Robarts Research Institute
Canada

Exp Neurol 2008 Dec 26;214(2):160-7. Epub 2008 Sep 26.

Spinal Cord Injury Laboratory, BioTherapeutics Research Group, Robarts Research Institute, Schulich School of Medicine and Dentistry, The University of Western Ontario, PO Box 5015, 100 Perth Drive, London, Ontario Canada.

Our previous studies have shown that treatment with an alpha4beta1 integrin blocking antibody after spinal cord injury (SCI) in rats decreases intraspinal inflammation and oxidative damage, improving neurological function. Here, we studied effects of a high affinity small molecule alpha4beta1 inhibitor, BIO5192. First, rats were treated intravenously with BIO5192 (10 mg/kg) or with vehicle (controls) to assess effects of integrin blockade for 24 h or 72 h after thoracic clip-compression SCI. BIO5192 treatment significantly decreased the MPO enzymatic activity (neutrophil infiltration) and ED-1 expression (macrophage density) by 40% and 38% at 24 h and by 52% and 25% at 72 h post injury, respectively. In cord homogenates, BIO5192 treatment decreased expression of the oxidative enzymes gp91(phox), inducible nitric oxide and cyclooxygenase-2 by approximately 40% at both times of analysis. Free radical concentration decreased by 30% and lipid peroxidation decreased by 34% and 46%, respectively, at 24 h and 72 h after SCI. Next, after blockade by BIO5192 for 72 h, neurological outcomes were analyzed for 1-6 weeks after SCI. Motor function significantly improved when assessed by an open-field test. Treated rats planter placed their hind paws and/or dorsal stepped, with weight support, whereas controls only swept their hindlimbs. BIO5192 treatment also decreased mechanical allodynia elicited from the trunk and hind paw by up to 35%. This improved function correlated with decreased lesion size and spared myelin-containing white matter. The neurological improvement offered by this neuroprotective strategy supports the potential for an anti-integrin treatment for SCI.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.expneurol.2008.09.006DOI Listing
December 2008
18 Reads

Publication Analysis

Top Keywords

bio5192 treatment
12
treatment decreased
12
neurological function
8
oxidative damage
8
spinal cord
8
cord injury
8
decreased
6
bio5192
6
sci
5
treatment
5
30% lipid
4
lipid peroxidation
4
peroxidation decreased
4
decreased 34%
4
decreased 30%
4
ed-1 expression
4
free radical
4
radical concentration
4
concentration decreased
4
34% 46%
4

Similar Publications